8-K ·Filed Mar 4, 2026

VEEV

VEEVA SYSTEMS INC
BULLISH
Impact 8/10
Horizonweeks Processed7mo ago SEC0001393052-26-000007
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The strong results and raised guidance suggest Veeva is successfully executing its strategy in the life sciences cloud market. Traders should monitor the company's AI integration progress and customer expansion, particularly in the Development and Quality Cloud segments, as key drivers of future growth.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
VEEV ▼ -3.38% at T+60d
LONG call ✗ call lost -3.38% · α vs SPY -14.68% · entry $195.27 → $188.66
Entry anchored
Mar 4, 03:59 PM ET
via exchange tick
T+1d
-0.20%
call -0.20% · α +1.11%
$194.87
settled 7mo ago
T+5d
-7.57%
call -7.57% · α -5.34%
$180.48
settled 7mo ago
T+20d
-10.96%
call -10.96% · α -7.18%
$173.86
settled 6mo ago
T+60d
-3.38%
call -3.38% · α -14.68%
$188.66
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Veeva Systems reported strong fiscal year 2026 results with $3.195 billion in revenue, up 16% year-over-year, and $908.9 million in net income, up 27%. The company raised its guidance for fiscal 2027, projecting revenue between $3.585-$3.6 billion, reflecting continued momentum in its life sciences cloud solutions and AI initiatives.

Key Financial Metrics

Revenue
$3.2B
+16.0% YoY
Adj. EPS
$8.10
GAAP: $5.44
Guidance
$3.585-$3.6 billion
raised
Gross Margin
75.5%

Key Facts

  • Fiscal 2026 revenue: $3.195 billion (16% YoY growth)
  • Fiscal 2026 net income: $908.9 million (27% YoY growth)
  • Q4 revenue: $836 million (16% YoY growth)
  • Raised FY2027 revenue guidance to $3.585-$3.6 billion
  • Non-GAAP net income per share of $8.10 for FY2026

Financial Impact

Revenue growth of 16% and net income growth of 27% year-over-year, with guidance indicating continued strong performance

revenuenet incomeeps

Segment Breakdown

SegmentRevenueGrowth
Subscription$2.7B+17.0%
Commercial Solutions$1.3B—
R&D and Quality Solutions$1.4B—

Risk Factors

  • Increased competition in cloud solutions for life sciences
  • Dependence on continued innovation in AI and cloud technologies
  • Potential macroeconomic headwinds affecting pharmaceutical industry spending

Market Snapshot

Exchange
NYSE

Investment Themes

Software & IT

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001393052-26-000007
Document: veev-20260304.htm0001393052-26-000007
Document: 0001393052-26-000007-index-headers.html0001393052-26-000007
Document: 0001393052-26-000007-index.html0001393052-26-000007
Document: 0001393052-26-000007.txt0001393052-26-000007
5 reports for VEEV
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VEEV — sortable, filterable
TypeNow
Aug 26, 2026
5w ago
Press Release
BULLISH ★ 7/10
$282.13 $278.39▼ −1.33%▼ −1.22%$274.52 (−2.70%)
Jun 3, 2026
17w ago
8-K
BULLISH ★ 7/10
$178.54 $192.74▲ +7.96%▲ +9.58%$274.52 (+53.76%)
May 4, 2026
21w ago
DEFA14A
NEUTRAL ★ 3/10
$170.18 $188.66▲ +10.86%▲ +5.22%$274.52 (+61.31%)
Apr 20, 2026
23w ago
8-K
NEUTRAL ★ 3/10
$167.71 $163.85▼ −2.30%▼ −7.21%$274.52 (+63.69%)
Mar 4, 2026
30w ago
8-K
BULLISH ★ 8/10
$195.27 $173.86▼ −10.96%▼ −7.18%$274.52 (+40.59%)
Showing 5 of 5

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access